Example: Heart Attack

Clinical Trials on Resectable Sarcoma

Total 4341 results

NCT07823491

Not yet recruiting

Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall

Resectable Soft Tissue Sarcoma | Resectable Undifferentiated Pleomorphic Sarcoma | Resectable Liposarcoma
NCT05711615

Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Metastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Metastatic Sarcoma | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Unresectable Synovial Sarcoma | Metastatic Myxofibrosarcoma | Unresectable Undifferentiated Pleomorphic Sarcoma | Metastatic Dedifferentiated Liposarcoma | Unresectable Dedifferentiated Liposarcoma
NCT06571734

Recruiting

XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma

Ewing Sarcoma | Bone Sarcoma | Sarcoma Metastatic | Osteosarcoma Metastatic | Metastatic Leiomyosarcoma | Unresectable Leiomyosarcoma | Sarcoma of Bone | Synovial Sarcomas | Ewing Sarcoma Metastatic | Translocation-associated Soft Tissue Sarcoma
NCT03805022

Recruiting

Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas (CIRSARC)

Resectable | Non-metastatic Soft-tissue Sarcoma
NCT04199026

Recruiting

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

Metastatic Sarcoma | Resectable Sarcoma | Recurrent Sarcoma

This is a preview
Log in or create a free account to see all matching trials and use the full search.
Log in | Register